Access to Medicines in Tajikistan

Dear colleagues,

Have you ever wondered what access to medicines is like in Tajikistan?

We have the pleasure of inviting you to take a look at the WHO/Europe publication on medicines prices and consumption in this Central Asia Republic, which also highlights:

  • Total expenditure on medicines and the portion covered with public funds

  • Essential vs non-essential medicines in consumption structure

  • Role of the local industry

  • Outcomes of economic modelling for pricing of medicines proposed for the first iteration of the positive/reimbursement list and other useful information.

This research was made possible thanks to EU’s co-funding and is part of the advocacy efforts for rolling out a reimbursement system in the country.

Please click one of these links to download the publication:

https://iris.who.int/handle/10665/383652

https://www.who.int/europe/publications/i/item/WHO-EURO-2025-12395-52169-80118

https://www.who.int/tajikistan/publications/i/item/WHO-EURO-2025-12395-52169-80118

Happy reading!

Best regards,

Stanislav Kniazkov